Intestinal Research

Inflammatory bowel diseases
Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases: Sang Hyoung Park, Jae Cheol Park, Milan Lukas, Martin Kolar, Edward V. Loftus, Jr; Intest Res. 2020;18(1):34-44. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.09147
Web of Science 19 Crossref 18; Full text PubReader ePub PDF

Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases: Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen, IBD Research Group of the Korean Association for the Study of Intestinal Diseases; Intest Res. 2020;18(1):18-33. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.09155
Web of Science 15 Crossref 18; Full text PubReader ePub PDF

Pediatric to adult inflammatory bowel disease transition: the Asian experience: Bernice Tan, David Ong; Intest Res. 2020;18(1):11-17. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.09144
Web of Science 12 Crossref 12; Full text PubReader ePub PDF

Update of endoscopic management of Crohn’s disease strictures: Akshay Pokala, Bo Shen; Intest Res. 2020;18(1):1-10. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.09158
Web of Science 11 Crossref 14; Full text PubReader ePub PDF

IBD
Stroke and neck bruit in a boy with Crohn’s disease: Ryosaku Tomiyama, Akira Hokama, Erika Koga, Kohei Shimabukuro, Yuiko Oishi, Tetsuya Ohira, Atsushi Iraha, Tetsu Kinjo, Jiro Fujita; Intest Res. 2019;17(4):565-566. Published online April 15, 2019; DOI: https://doi.org/10.5217/ir.2019.00019; Full text PubReader ePub PDF

Inflammatory bowel diseases
Infliximab biosimilar CT-P13 is interchangeable with its originator for patients with inflammatory bowel disease in real world practice: Tomoo Nakagawa, Taku Kobayashi, Kiyohiro Nishikawa, Fumika Yamada, Satoshi Asai, Yukinori Sameshima, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi; Intest Res. 2019;17(4):504-515. Published online August 23, 2019; DOI: https://doi.org/10.5217/ir.2019.00030
Web of Science 13 Crossref 15; Full text PubReader ePub PDF

Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study: Jingzhou Wang, Takahiro I Nakamura, Anne G Tuskey, Brian W Behm; Intest Res. 2019;17(4):496-503. Published online October 14, 2019; DOI: https://doi.org/10.5217/ir.2019.00050
Web of Science 16 Crossref 16; Full text PubReader ePub PDF

Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior: Rupa Banerjee, Partha Pal, Susan Hutfless, B Girish Ganesh, D Nageshwar Reddy; Intest Res. 2019;17(4):486-495. Published online August 6, 2019; DOI: https://doi.org/10.5217/ir.2018.00174
Web of Science 16 Crossref 16; Full text PubReader ePub PDF

Tacrolimus for ulcerative colitis in children: a multicenter survey in Japan: Tadahiro Yanagi, Kosuke Ushijima, Hidenobu Koga, Takeshi Tomomasa, Hitoshi Tajiri, Reiko Kunisaki, Takashi Isihige, Hiroyuki Yamada, Katsuhiro Arai, Atsushi Yoden, Tomoki Aomatsu, Satoru Nagata, Keiichi Uchida, Yoshikazu Ohtsuka, Toshiaki Shimizu; Intest Res. 2019;17(4):476-485. Published online August 31, 2019; DOI: https://doi.org/10.5217/ir.2019.00027
Web of Science 10 Crossref 8; Full text PubReader ePub PDF Supplementary Material

IBD
Nutritional approach as therapeutic manipulation in inflammatory bowel disease: Jin Young Yoon; Intest Res. 2019;17(4):463-475. Published online October 28, 2019; DOI: https://doi.org/10.5217/ir.2019.00078
Web of Science 4 Crossref 4; Full text PubReader ePub PDF

Tacrolimus in pediatric ulcerative colitis: does it have a role?: Seung Kim; Intest Res. 2019;17(4):441-442. Published online October 28, 2019; DOI: https://doi.org/10.5217/ir.2019.00124; Full text PubReader ePub PDF

A pulmonary nodule in a patient with Crohn’s disease: Akira Hokama, Shusaku Haranaga, Takanobu Sasaki, Hirofumi Matsumoto, Tetsuya Ohira, Atsushi Iraha, Tetsu Kinjo, Saifun Nahar, Jiro Fujita; Intest Res. 2019;17(3):438-439. Published online February 11, 2019; DOI: https://doi.org/10.5217/ir.2019.00010; Full text PubReader ePub PDF

Inflammatory bowel diseases
Quantitative histology-based classification system for assessment of the intestinal mucosal histological changes in patients with celiac disease: Prasenjit Das, Gaurav PS Gahlot, Alka Singh, Vandana Baloda, Ramakant Rawat, Anil K Verma, Gaurav Khanna, Maitrayee Roy, Archana George, Ashok Singh, Aasma Nalwa, Prashant Ramteke, Rajni Yadav, Vineet Ahuja, Vishnubhatla Sreenivas, Siddhartha Datta Gupta, Govind K Makharia; Intest Res. 2019;17(3):387-397. Published online April 22, 2019; DOI: https://doi.org/10.5217/ir.2018.00167
Web of Science 12 Crossref 13; Full text PubReader ePub PDF

Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study: Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki; Intest Res. 2019;17(3):375-386. Published online February 12, 2019; DOI: https://doi.org/10.5217/ir.2018.00141
Web of Science 15 Crossref 14; Full text PubReader ePub PDF

Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis: Alissa Walsh, Lawrence Matini, Christopher Hinds, Vanashree Sexton, Oliver Brain, Satish Keshav, John Geddes, Guy Goodwin, Gary Collins, Simon Travis, Michele Peters; Intest Res. 2019;17(3):365-374. Published online May 31, 2019; DOI: https://doi.org/10.5217/ir.2018.00173
Web of Science 11 Crossref 12; Full text PubReader ePub PDF

IBD